Error message

The page you requested does not exist. For your convenience, a search was performed using the query news events press coverage 2017 10 26.

Page not found

You are here

Tue, October 31, 2017

In a recent US Department of Health and Human Services symposium, Kayte Spector-Bagdady discussed the need for consistent informed consent and disclosure regulations for biospecimens and health data.

Mon, January 06, 2014

Dr. Reshma Jagsi worked on a study detailing the decline of US research spending versus the increase in spending in Japan and China. In the UMHS article, she says, "The United States has long been a world leader in driving research and development in the biomedical science. It's important to maintain that leadership role because biomedical research has a number of long term downstream economic benefits, especially around job creation," 

Research Topics: 

PIHCD-Ken Pituch

Thu, May 11, 2017, 4:00pm
Location: 
NCRC bldg 16 B004E

Topic: ICU tracheostomy decisions  the lens of professor Yates’ 10 cardinal issues in good decision making that is well respected in non-medical settings

CBSSM Seminar: Lisa Lehmann, MD, PhD, MSc

Fri, June 09, 2017, 3:00pm
Location: 
NCRC, Building 10, G065

Lisa Lehmann, MD, PhD, MSc
Executive Director, National Center for Ethics in Health Care
U.S. Department of Veterans Affairs

"Moral Distress in Health Care: The Role of Courage and Culture"

Working Group Meeting- Kayte Spector-Bagdady

Wed, September 20, 2017, 4:00pm
Location: 
NCRC Bldg 10 G065

Kayte is seeking feedback on the aims page of a grant she is submitting about informed consent to expanded carrier screening and the tension between the clinical and research value of genetic data.

Working Group Meeting- Jeff Dewitt

Tue, October 10, 2017, 4:00pm
Location: 
NCRC bldg 16 266C

Jeff will be seeking feedback on a survey looking for reactions to different pictographs that might be used as decision aids in communicating the risks/benefits of lung cancer screening.

Tue, July 26, 2011
The Department of Health and Human Services published an Advance Notice of Proposed Rulemaking to request comment on how current regulations for protecting human subjects who participate in research might be modernized and revised to be more effective.  Changes are proposed to seven aspects of the current regulatory framework:
 
  • refinement of the existing risk-based regulatory framework;
  • utilization of a single IRB review of record for domestic sites of multi-site studies;
  • improvement of consent forms and the consent process;
  • establishment of mandatory data security and information protection standards for all studies involving identifiable data;
  • establishment of an improved, more systematic approach for the collection and analysis of data on unanticipated problems and adverse events;
  • extension of Federal regulatory protections to all research, regardless of funding source, conducted at institutions in the U.S. receiving some Federal funding from a Common Rule agency for research with human subjects; and
  • improvement in the harmonization of regulations and related agency guidance

The paper, "Pruning the regulatory tree: For human subjects research, maximum regulation does not mean maximum protection," authored by CBSSM faculty Scott Kim, Peter Ubel, and Ray De Vries, was cited in the ANPRM.

 

Tue, September 26, 2017

Dean Shumway, Rochelle Jones, Sarah Hawley, and Reshma Jagsi are co-authors of a study, published in the Annals of Surgical Oncology, which found that clinician attitudes and patient expectations are driving overtreatment of radiotherapy in older breast cancer patients.

Thu, October 26, 2017

In a new analysis in Health Affairs, CBSSM's Jeffrey Kullgren and fellow researchers found that while the "Choosing Wisely" campaign to reduce overtesting and overtreatment is off to a strong start, more work is still needed to cut back on low-value care.

Pages